Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1/2 4Phase NA 2Phase 4 1Phase 1 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 3FED 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1Dermatologic 1

Conditions

Prostatic Neoplasms 1Mouth Neoplasms 1Melanoma 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 143pembrolizumab 127Nivolumab 116Carboplatin 99Dexamethasone 93Rituximab 91Paclitaxel 87Gemcitabine 85Lenalidomide 75Cytarabine 74Radiotherapy 73Cisplatin 70Bevacizumab 64Etoposide 62fludarabine phosphate 58fludarabine 56Ipilimumab 55Docetaxel 54Bortezomib 54Prednisone 49Doxorubicin 48Temozolomide 47Everolimus 46Erlotinib Hydrochloride 46Fluorouracil 44Azacitidine 44Capecitabine 43Calcium Dobesilate 43Filgrastim 42Melphalan 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Has results × Calcitriol × Clear all
NCT00301067 2019-06-04

Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma

Northwestern University

Phase 1/2 Completed
20 enrolled 9 charts
Dermatologic

Melanoma

NCT00794547 2017-12-12

Phase I/II Calcitriol in Lung Cancer

University of Michigan Rogel Cancer Center

Phase 1/2 Terminated
34 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00536991 2017-06-14

Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer

Roswell Park Cancer Institute

Phase 1/2 Terminated
51 enrolled 11 charts
Genitourinary

Prostatic Neoplasms

NCT00953849 2017-03-07

Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity

VA Office of Research and Development

Phase 1/2 Completed
21 enrolled 10 charts
Head & Neck

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡